We just announced a $1.5 billion investment in support of the first-ever National Strategy for Rare Diseases!

1/12 Canadians, including many children, have a rare disease, and only a small percentage of these conditions have treatments—most are unaffordable and out of reach.
Delivered over 3 years, the funding will help patients, have better access to screening, diagnostics, and affordable effective medicines.
We need to ensure that kids, that all patients, have access to testing and treatment as soon as possible to improve outcomes and their quality of life!
I want you to know that we will continue working with the provinces and territories to improve access to medicine, while advancing Pharmacare legislation and working to establish a Canadian Drug Agency.

2024-03-08T18:31:35-04:00